SW
ATRA icon

SVB Wealth’s Atara Biotherapeutics ATRA Stock Holding History

SVB Wealth’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-421
Closed -$2.5K – 575
2025
Q1 		$2.5K Buy
+421
New +$3.67K ﹤0.01% 1184
2024
Q2 		– Sell
-843
Closed -$14.6K – 753
2024
Q1 		$14.6K Hold
843
– – ﹤0.01% 847
2023
Q4 		$10.8K Buy
843
+400
+90% +$9.33K ﹤0.01% 868
2023
Q3 		$16.4K Sell
443
-6,632
-94% -$295K ﹤0.01% 850
2023
Q2 		$285K Hold
7,075
– – 0.01% 696
2023
Q1 		$513K Sell
7,075
-1
-0% -$97 0.01% 527
2022
Q4 		$580K Sell
7,076
-5
-0.1% -$521 0.01% 525
2022
Q3 		$669K Buy
+7,081
New +$795K 0.01% 457

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return